Micro and nanosystems for delivering local anesthetics

Bibliography

• McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anestesiol 2005;71:59-74
   PubMedGoogle Scholar
• Rose JS, Neal JM, Kopacz DJ. Extended-duration analgesia: update on microspheres and liposomes. Reg Anesth Pain Med 2005;30:275-85
   PubMed Web of Science ®Google Scholar
• Weiniger CF, Golovanevski M, Sokolsky-Papkov M, Domb AJ. Review of prolonged local anesthetic action. Expert Opin Drug Deliv 2010;7:737-52
   PubMed Web of Science ®Google Scholar
• Scholz A. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth 2002;89:52-61
   PubMed Web of Science ®Google Scholar
• Yanagidate F, Strichartz GR. Bupivacaine inhibits activation of neuronal spinal extracellular receptor-activated kinase through selective effects on ionotropic receptors. Anesthesiology 2006;104:805-14
   PubMed Web of Science ®Google Scholar
• Strichartz GR. Novel ideas of local anaesthetic actions on various ion channels to ameliorate postoperative pain. Br J Anaesth 2008;101:45-7
   PubMed Web of Science ®Google Scholar
• Malamed S. What's new in local anaesthesia? SAAD Dig 2009;25:4-14
   PubMedGoogle Scholar
• Wiles MD, Nathanson MH. Local anaesthetics and adjuvants–future developments. Anaesthesia 2010;65:22-37
   PubMed Web of Science ®Google Scholar
• Lagan G, McLure HA. Review of local anaesthetic agents. Curr Anaesth Crit Care 2004;15:247-54
   Google Scholar
• Columb MO, MacLennan K. Local anaesthetic agents. Anaesth Intensive Care Med 2007;8:159-62
   Google Scholar
• Mulroy MF, Larkin KL, Batra MS, Femoral nerve block with 0.25% or 0.5% bupivacaine improves postoperative analgesia following outpatient arthroscopic anterior cruciate ligament repair. Reg Anesth Pain Med 2001;26:24-9
   PubMed Web of Science ®Google Scholar
• Davidson EM, Barenholz Y, Cohen R, High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans. Anesth Analg 2010;110:1018-23
   PubMed Web of Science ®Google Scholar
• Takenami T, Wang G, Nara Y, Intrathecally administered ropivacaine is less neurotoxic than procaine, bupivacaine, and levobupivacaine in a rat spinal model. Can J Anaesth 2012;59:456-65
   PubMed Web of Science ®Google Scholar
• Werdehausen R, Braun S, Hermanns H, The influence of adjuvants used in regional anesthesia on lidocaine-induced neurotoxicity in vitro. Reg Anesth Pain Med 2011;36:436-43
   PubMed Web of Science ®Google Scholar
• Grant SA, Nielsen KC, Greengrass RA, Continuous peripheral nerve block for ambulatory surgery. Reg Anesth Pain Med 2001;26:209-14
   PubMed Web of Science ®Google Scholar
• Klein SM, Grant SA, Greengrass RA, Interscalene brachial plexus block with a continuous catheter insertion system and a disposable infusion pump. Anesth Analg 2000;91:1473-8
   PubMed Web of Science ®Google Scholar
• Battaglia L, Gallarate M. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 2012;9:497-508
   PubMed Web of Science ®Google Scholar
• Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 2012;9:429-41
   PubMed Web of Science ®Google Scholar
• Mura P, Maestrelli F, González-Rodríguez ML, Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm 2007;67:86-95
   PubMed Web of Science ®Google Scholar
• Shim J, Kim MJ, Kim HK, Morphological effect of lipid carriers on permeation of lidocaine hydrochloride through lipid membranes. Int J Pharm 2010;388:251-6
   PubMed Web of Science ®Google Scholar
• Padula C, Fulgoni A, Santi P. In vivo stratum corneum distribution of lidocaine, assessed by tape stripping, from a new bioadhesive film. Skin Res Technol 2010;16:125-30
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Funk A, Fallon-Friedlander S, Cunningham BB. A clinical study to evaluate the efficacy of ELA-Max (4% liposomal lidocaine) as compared with eutectic mixture of local anesthetics cream for pain reduction of venipuncture in children. Pediatrics 2002;109:1093-9
   PubMed Web of Science ®Google Scholar
• Fraceto LF, Spisni A, Schreier S, de Paula E. Differential effects of uncharged aminoamide local anesthetics on phospholipid bilayers, as monitored by 1H-NMR measurements. Biophys Chem 2005;115:11-18
   PubMed Web of Science ®Google Scholar
• Malheiros SV, Pinto LM, Gottardo L, A new look at the hemolytic effect of local anesthetics, considering their real membrane/water partitioning at pH 7.4. Biophys Chem 2004;110:213-21
   PubMed Web of Science ®Google Scholar
• de Paula E, Schreier S. Use of a novel method for determination of partition coefficients to compare the effect of local anesthetics on membrane structure. Biochim Biophys Acta 1995;1240:25-33
   PubMed Web of Science ®Google Scholar
• de Paula E, Cereda C, Tofoli G, Drug delivery systems for local anesthetics. Recent Pat Drug Deliv Formul 2010;4:23-34
   PubMedGoogle Scholar
• Rao JP, Geckeler KE. Cyclodextrin supramacromolecules: unexpected formation in aqueous phase under ambient conditions. Macromol Rapid Commun 2011;32:426-30
   PubMed Web of Science ®Google Scholar
• Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. Chem Pharm Bull (Tokyo) 1981;29:3363-8
   PubMed Web of Science ®Google Scholar
• Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine. Chem Pharm Bull (Tokyo) 1982;30:3719-27
   PubMed Web of Science ®Google Scholar
• Estebe JP, Le Corre P, Mallédant Y, Prolongation of spinal anesthesia with bupivacaine-loaded (DL-lactide) microspheres. Anesth Analg 1995;81:99-103
   PubMed Web of Science ®Google Scholar
• Le Corre P, Le Guevello P, Gajan V, Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres. Int J Pharm 1994;107:41-9
   Web of Science ®Google Scholar
• Curley J, Castillo J, Hotz J, Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996;84:1401-10
   PubMed Web of Science ®Google Scholar
• Kopacz DJ, Bernards CM, Allen HW, A model to evaluate the pharmacokinetic and pharmacodynamic variables of extended-release products using in vivo tissue microdialysis in humans: bupivacaine-loaded microcapsules. Anesth Analg 2003;97:124-31
   PubMed Web of Science ®Google Scholar
• Pedersen JL, Lillesø J, Hammer NA, Bupivacaine in microcapsules prolongs analgesia after subcutaneous infiltration in humans: a dose-finding study. Anesth Analg 2004;99:912-18
   PubMed Web of Science ®Google Scholar
• Görner T, Gref R, Michenot D, Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix. J Control Release 1999;57:259-68
   PubMed Web of Science ®Google Scholar
• Polakovic M, Görner T, Gref R, Dellacherie E. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J Control Release 1999;60:169-77
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 1999;57:171-85
   PubMed Web of Science ®Google Scholar
• Klose D, Siepmann F, Elkharraz K, How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int J Pharm 2006;314:198-206
   PubMed Web of Science ®Google Scholar
• Moraes CM, de Matos AP, de Lima R, Initial development and characterization of PLGA nanospheres containing ropivacaine. J Biol Phys 2007;33:455-61
   PubMed Web of Science ®Google Scholar
• Holgado MA, Arias JL, Cózar MJ, Synthesis of lidocaine-loaded PLGA microparticles by flow focusing. Effects on drug loading and release properties. Int J Pharm 2008;358:27-35
   PubMed Web of Science ®Google Scholar
• Zhang H, Lu Y, Zhang G, Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Int J Pharm 2008;351:244-9
   PubMed Web of Science ®Google Scholar
• Horie RT, Sakamoto T, Nakagawa T, Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles. Laryngoscope 2010;120:377-83
   PubMed Web of Science ®Google Scholar
• de Melo NFS, Grillo R, Rosa AH, Desenvolvimento e caracterização de nanocápsulas de poli(L-lactideo) contendo benzocaína. Química Nova 2010;33:65-9
   Google Scholar
• Moraes CM, Matos AP, de Paula E, Benzocaine loaded biodegradable poly(D,L-lactide-co-glycolide) nanocapsules: factorial design and characterization. Mater Sci Eng B 2009;165:243-6
   Web of Science ®Google Scholar
• Moraes CM, de Paula E, Rosa AH, Fraceto LF. Physicochemical stability of poly(lactide-co-glycolide) nanocapsules containing the local anesthetic bupivacaine. J Braz Chem Soc 2010;6:995-1000
   Google Scholar
• Moraes CM, Matos AP, de Paula E, Solid state materials for advanced technology. Mater Sci Eng B 2009;165:243
   Web of Science ®Google Scholar
• Grillo R, de Melo NFS, de Araújo DR, Polymeric alginate nanoparticles containing the local anesthetic bupivacaine. J Drug Target 2010;18:688-99
   PubMed Web of Science ®Google Scholar
• de Melo NFS, de Araújo DR, Grillo R, Benzocaine-loaded polymeric nanocapsules: study of the anesthetic activities. J Pharm Sci 2012;101:1157-65
   PubMed Web of Science ®Google Scholar
• de Melo NFS, Grillo R, Guilherme VA, Poly(lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity. Pharm Res 2011;28:1984-94
   PubMed Web of Science ®Google Scholar
• Nel AE, Mädler L, Velegol D, Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009;8:543-57
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. J Pharm Pharmacol 2011;63:1119-35
   PubMed Web of Science ®Google Scholar
• Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 2004;3:1023-35
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1-11
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645-66
   PubMed Web of Science ®Google Scholar
• Dollo G, Le Corre P, Chevanne F, Le Verge R. Inclusion complexation of amide-typed local anesthetics with β-cyclodextrin and its derivatives. I. Physicochemical characterization. Int J Pharm 1996;131:165-74
   Google Scholar
• Rajewski RA, Stella VJ. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 1996;85:1142-69
   PubMed Web of Science ®Google Scholar
• Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 1997;86:147-62
   PubMed Web of Science ®Google Scholar
• Moraes CM, Abrami P, de Paula E, Study of the interaction between S(–) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin. Int J Pharm 2007;331:99-106
   PubMed Web of Science ®Google Scholar
• de Araújo DR, Tsuneda SS, Cereda CM, Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex. Eur J Pharm Sci 2008;33:60-71
   PubMed Web of Science ®Google Scholar
• Moraes CM, Abrami P, de Araújo DR, Characterization of lidocaine:hydroxypropyl-β-cyclodextrin inclusion complex. J Incl Phenom Macrocycl Chem 2007;57:313-16
   Web of Science ®Google Scholar
• Cabeça LF, Figueiredo IM, de Paula E, Marsaioli AJ. Prilocaine–cyclodextrin–liposome: effect of pH variations on the encapsulation and topology of a ternary complex using 1H NMR. Magn Reson Chem 2011;49:295-300
   PubMed Web of Science ®Google Scholar
• Pinto LM, Fraceto LF, Santana MH, Physico-chemical characterization of benzocaine-beta-cyclodextrin inclusion complexes. J Pharm Biomed Anal 2005;39:956-63
   PubMed Web of Science ®Google Scholar
• Cabeça LF, Fernandes SA, de Paula E, Marsaioli AJ. Topology of a ternary complex (proparacaine-beta-cyclodextrin-liposome) by STD NMR. Magn Reson Chem 2008;46:832-7
   PubMed Web of Science ®Google Scholar
• de Lima RAF, de Jesus MB, Cereda CMS, Improvement of tetracaine antinociceptive effect by inclusion in cyclodextrins. J Drug Target 2012;20:85-96
   PubMed Web of Science ®Google Scholar
• Meert TF, Melis W. Interactions between epidurally and intrathecally administered sufentanil and bupivacaine in hydroxypropyl-beta-cyclodextrin in the rat. Acta Anaesthesiol Belg 1992;43:79-89
   PubMedGoogle Scholar
• Dollo G, Le Corre P, Chevanne F, Le Verge R. Inclusion complexation of amide-typed local anesthetics with β-cyclodextrin and its derivatives. II. Evaluation of affinity constants and in vitro transfer rate constants. Int J Pharm 1996;136:219-28
   Google Scholar
• Dollo G, Thompson DO, Le Corre P, Inclusion complexation of amide-typed local anesthetics with β-cyclodextrin and its derivatives. III. Biopharmaceutics of bupivacaine-SBE7-β-CD complex following percutaneous sciatic nerve administration in rabbits. Int J Pharm 1998;164:11-19
   Web of Science ®Google Scholar
• Al-nouti Y, Bartlett MG. Comparison of local anesthetic-cyclodextrin non-covalent complexes using capillary electrophoresis and electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 2002;13:928-35
   PubMed Web of Science ®Google Scholar
• Fréville JC, Dollo G, Le Corre P, Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-beta-cyclodextrin complex. Pharm Res 1996;13:1576-80
   PubMed Web of Science ®Google Scholar
• Estebe JP, Ecoffey C, Dollo G, Bupivacaine pharmacokinetics and motor blockade following epidural administration of the bupivacaine-sulphobutylether 7-beta-cyclodextrin complex in sheep. Eur J Anaesthesiol 2002;19:308-10
   PubMed Web of Science ®Google Scholar
• Araújo DR, Fraceto LF, Braga AeF, Paula E. Drug-delivery systems for racemic bupivacaine (S50-R50) and bupivacaine enantiomeric mixture (S75-R25): cyclodextrins complexation effects on sciatic nerve blockade in mice. Rev Bras Anestesiol 2005;55:316-28
   PubMedGoogle Scholar
• Araújo DR, Braga AFA, Moraes CM, Complexation of 50% enantiomeric excess (S75-R25) bupivacaine with cyclodextrins and spinal block anesthesia in rats. Rev Bras Anestesiol 2006;56:495-506
   PubMedGoogle Scholar
• Karashima K, Taniguchi M, Nakamura T, Prolongation of intrathecal and sciatic nerve blocks using a complex of levobupivacaine with maltosyl-beta-cyclodextrin in rats. Anesth Analg 2007;104:1121-8
   PubMed Web of Science ®Google Scholar
• Suzuki R, Arai YC, Hamayasu K, Complex of branched cyclodextrin and lidocaine prolonged the duration of peripheral nerve block. J Anesth 2009;23:295-7
   PubMed Web of Science ®Google Scholar
• Stella VJ, He Q. Cyclodextrins. Toxicol Pathol 2008;36:30-42
   PubMed Web of Science ®Google Scholar
• Frank DW, Gray JE, Weaver RN. Cyclodextrin nephrosis in the rat. Am J Pathol 1976;83:367-82
   PubMed Web of Science ®Google Scholar
• Frijlink HW, Eissens AC, Hefting NR, The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. Pharm Res 1991;8:9-16
   PubMed Web of Science ®Google Scholar
• Carpenter TO, Gerloczy A, Pitha J. Safety of parenteral hydroxypropyl beta-cyclodextrin. J Pharm Sci 1995;84:222-5
   PubMed Web of Science ®Google Scholar
• Gould S, Scott RC. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food Chem Toxicol 2005;43:1451-9
   PubMed Web of Science ®Google Scholar
• Rajewski RA, Traiger G, Bresnahan J, Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives. J Pharm Sci 1995;84:927-32
   PubMed Web of Science ®Google Scholar
• Cereda CM, Tofoli GR, Maturana LG, Local neurotoxicity and myotoxicity evaluation of cyclodextrin complexes of bupivacaine and ropivacaine. Anesth Analg 2012; In press
   PubMed Web of Science ®Google Scholar
• Kuzma PJ, Kline MD, Calkins MD, Staats PS. Progress in the development of ultra-long-acting local anesthetics. Reg Anesth 1997;22:543-51
   PubMedGoogle Scholar
• Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 2011;54:1552-9
   PubMed Web of Science ®Google Scholar
• Grant SA. The holy grail: long-acting local anaesthetics and liposomes. Best Pract Res Clin Anaesthesiol 2002;16:345-52
   PubMedGoogle Scholar
• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965;13:238-52
   PubMed Web of Science ®Google Scholar
• Lichtenberg D, Barenholz Y. Liposomes: preparation, characterization, and preservation. Methods Biochem Anal 1988;33:337-462
   PubMedGoogle Scholar
• Ranade VV. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers. J Clin Pharmacol 1989;29:685-94
   PubMed Web of Science ®Google Scholar
• Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007;4:297-305
   PubMedGoogle Scholar
• Grant GJ, Bansinath M. Liposomal delivery systems for local anesthetics. Reg Anesth Pain Med 2001;26:61-3
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-60
   PubMed Web of Science ®Google Scholar
• Nguyen S, Alund SJ, Hiorth M, Studies on pectin coating of liposomes for drug delivery. Colloids Surf B Biointerfaces 2011;88:664-73
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Liposomes in drug delivery. In: siegel RA, Rathbone MJ, editors, Drug delivery, advances in delivery science and technology. Control Release Soc 2012;11:289-328
   Google Scholar
• Sharata HH, Katz KH. Liposomes. Int J Dermatol 1996;35:761-9
   PubMed Web of Science ®Google Scholar
• Mowat JJ, Mok MJ, MacLeod BA, Madden TD. Liposomal bupivacaine. Extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradient. Anesthesiology 1996;85:635-43
   PubMed Web of Science ®Google Scholar
• Grant GJ, Barenholz Y, Bolotin EM, A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology 2004;101:133-7
   PubMed Web of Science ®Google Scholar
• Gesztes A, Mezei M. Topical anesthesia of the skin by liposome-encapsulated tetracaine. Anesth Analg 1988;67:1079-81
   PubMed Web of Science ®Google Scholar
• Langerman L, Grant GJ, Zakowski M, Prolongation of epidural anesthesia using a lipid drug carrier with procaine, lidocaine, and tetracaine. Anesth Analg 1992;75:900-5
   PubMed Web of Science ®Google Scholar
• Boogaerts JG, Lafont ND, Luo H, Legros FJ. Plasma concentrations of bupivacaine after brachial plexus administration of liposome-associated and plain solutions to rabbits. Can J Anaesth 1993;40:1201-4
   PubMed Web of Science ®Google Scholar
• Boogaerts J, Declercq A, Lafont N, Toxicity of bupivacaine encapsulated into liposomes and injected intravenously: comparison with plain solutions. Anesth Analg 1993;76:553-5
   PubMed Web of Science ®Google Scholar
• Grant GJ, Vermeulen K, Langerman L, Prolonged analgesia with liposomal bupivacaine in a mouse model. Reg Anesth 1994;19:264-9
   PubMedGoogle Scholar
• Grant GJ, Lax J, Susser L, Wound infiltration with liposomal bupivacaine prolongs analgesia in rats. Acta Anaesthesiol Scand 1997;41:204-7
   PubMed Web of Science ®Google Scholar
• Grant GJ, Barenholz Y, Piskoun B, DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice. Pharm Res 2001;18:336-43
   PubMed Web of Science ®Google Scholar
• Boogaerts J, Lafont N, Donnay M, Motor blockade and absence of local nerve toxicity induced by liposomal bupivacaine injected into the brachial plexus of rabbits. Acta Anaesthesiol Belg 1995;46:19-24
   PubMedGoogle Scholar
• Yu HY, Li SD, Sun P. Kinetic and dynamic studies of liposomal bupivacaine and bupivacaine solution after subcutaneous injection in rats. J Pharm Pharmacol 2002;54:1221-7
   PubMed Web of Science ®Google Scholar
• Malinovsky JM, Bernard JM, Le Corre P, Extradural bupivacaine-loaded microspheres and spinal cord blood flow in the chronically instrumented rabbit. Clin Physiol 1997;17:361-70
   PubMedGoogle Scholar
• Malinovsky JM, Le Corre P, Meunier JF, A dose-response study of epidural liposomal bupivacaine in rabbits. J Control Release 1999;60:111-19
   PubMed Web of Science ®Google Scholar
• Malinovsky JM, Benhamou D, Alafandy M, Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits. Anesth Analg 1997;85:1331-6
   PubMed Web of Science ®Google Scholar
• Yu HY, Sun P, Hou WY. Prolonged local anesthetic effect of bupivacaine liposomes in rats. Int J Pharm 1998;176:133-6
   Google Scholar
• Mashimo T, Uchida I, Pak M, Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine. Anesth Analg 1992;74:827-34
   PubMed Web of Science ®Google Scholar
• Cereda CM, de Araújo DR, Brunetto GB, De Paula E. Liposomal prilocaine: preparation, characterization, and in vivo evaluation. J Pharm Pharm Sci 2004;7:235-40
   PubMed Web of Science ®Google Scholar
• de Araújo DR, Cereda CM, Brunetto GB, Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice. Can J Anaesth 2004;51:566-72
   PubMed Web of Science ®Google Scholar
• Cereda CM, Brunetto GB, de Araújo DR, de Paula E. Liposomal formulations of prilocaine, lidocaine and mepivacaine prolong analgesic duration. Can J Anaesth 2006;53:1092-7
   PubMed Web of Science ®Google Scholar
• de Araújo DR, Cereda CM, Brunetto GB, Pharmacological and local toxicity studies of a liposomal formulation for the novel local anaesthetic ropivacaine. J Pharm Pharmacol 2008;60:1449-57
   PubMed Web of Science ®Google Scholar
• Boogaerts JG, Lafont ND, Declercq AG, Epidural administration of liposome-associated bupivacaine for the management of postsurgical pain: a first study. J Clin Anesth 1994;6:315-20
   PubMed Web of Science ®Google Scholar
• Lafont ND, Boogaerts JG, Legros FJ. Use of liposome-associated bupivacaine for the management of a chronic pain syndrome. Anesth Analg 1994;79:818
   PubMed Web of Science ®Google Scholar
• Lafont ND, Legros FJ, Boogaerts JG. Use of liposome-associated bupivacaine in a cancer pain syndrome. Anaesthesia 1996;51:578-9
   PubMed Web of Science ®Google Scholar
• Tofoli GR, Cereda CM, de Araújo DR, Pharmacokinetic and local toxicity studies of liposome-encapsulated and plain mepivacaine solutions in rats. Drug Deliv 2010;17:68-76
   PubMed Web of Science ®Google Scholar
• Parnham MJ, Wetzig H. Toxicity screening of liposomes. Chem Phys Lipids 1993;64:263-74
   PubMed Web of Science ®Google Scholar
• Kimelberg HK, Mayhew EG, Gregoriadis G. Properties and biological effects of liposomes and their uses in pharmacology and toxicology. Crit Rev Toxicol 1978;6:25-79
   Web of Science ®Google Scholar
• Cabeça LF, Figueiredo IM, de Paula E, Marsaioli AJ. Prilocaine-cyclodextrin-liposome: effect of pH variations on the encapsulation and topology of a ternary complex using 1H NMR. Magn Reson Chem 2011;49:295-300
   PubMed Web of Science ®Google Scholar
• Bragagni M, Maestrelli F, Mennini N, Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anesthetic efficacy. J Liposome Res 2010;20:315-22
   PubMed Web of Science ®Google Scholar
• Maestrelli F, González-Rodríguez ML, Rabasco AM, New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm 2010;395:222-31
   PubMed Web of Science ®Google Scholar
• Ullah I, Cadwallader DE. Dissolution of slightly soluble powders under sink conditions. 3. Transport of drug solution across screens and membrane barriers. J Pharm Sci 1971;60:1496-9
   PubMed Web of Science ®Google Scholar
• Franz-Montan M, Bergamaschi C, de Paula E, Pharmacokinetic profile of liposome-encapsulated ropivacaine after maxillary infiltration anaesthesia. J Braz Chem Soc 2010;10:1945-51
   Google Scholar
• Tofoli GR, Cereda CM, Araújo DR, Pharmacokinetic study of liposome-encapsulated and plain mepivacaine formulations injected intra-orally in volunteers. J Pharm Pharmacol 2012;64:397-403
   PubMed Web of Science ®Google Scholar
• Kranz H, Yilmaz E, Brazeau GA, Bodmeier R. In vitro and in vivo drug release from a novel in situ forming drug delivery system. Pharm Res 2008;25:1347-54
   PubMed Web of Science ®Google Scholar
• Ratajczak-Enselme M, Estebe JP, Dollo G, Epidural, intrathecal and plasma pharmacokinetic study of epidural ropivacaine in PLGA-microspheres in sheep model. Eur J Pharm Biopharm 2009;72:54-61
   PubMed Web of Science ®Google Scholar
• Adams L. Adjuvants to local anaesthesia in ophthalmic surgery. Br J Ophthalmol 2011;95:1345-9
   PubMed Web of Science ®Google Scholar
• Roghani S, Duperon DF, Barcohana N. Evaluating the efficacy of commonly used topical anesthetics. Pediatr Dent 1999;21:197-200
   PubMedGoogle Scholar
• McMillan AS, Walshaw D, Meechan JG. The efficacy of Emla and 5% lignocaine gel for anaesthesia of human gingival mucosa. Br J Oral Maxillofac Surg 2000;38:58-61
   PubMed Web of Science ®Google Scholar
• Alqareer A, Alyahya A, Andersson L. The effect of clove and benzocaine versus placebo as topical anesthetics. J Dent 2006;34:747-50
   PubMed Web of Science ®Google Scholar
• Bucalo BD, Mirikitani EJ, Moy RL. Comparison of skin anesthetic effect of liposomal lidocaine, nonliposomal lidocaine, and EMLA using 30-minute application time. Dermatol Surg 1998;24:537-41
   PubMed Web of Science ®Google Scholar
• de Araújo DR, Pinto LM, Braga AF, de Paula E. Drug-delivery systems for local anesthetics: therapeutic applications. Rev Bras Anestesiol 2003;53:663-71
   PubMedGoogle Scholar
• Viscusi ER. Liposomal drug delivery for postoperative pain management. Reg Anesth Pain Med 2005;30:491-6
   PubMed Web of Science ®Google Scholar
• Malamed SF. Handbook of Local Anesthesia. 5th edition. St. Louis, CV Mosby; 2004
   Google Scholar
• Wiziack Zago PM, Baroni DB, Groppo FC, Anesthetic efficacy of liposomal prilocaine in maxillary infiltration anesthesia. J Liposome Res 2011;21:81-7
   PubMed Web of Science ®Google Scholar
• Pérusse R, Goulet JP, Turcotte JY. Contraindications to vasoconstrictors in dentistry: part I. Cardiovascular diseases. Oral Surg Oral Med Oral Pathol 1992;74:679-86
   PubMedGoogle Scholar
• Pérusse R, Goulet JP, Turcotte JY. Contraindications to vasoconstrictors in dentistry: part II. Hyperthyroidism, diabetes, sulfite sensitivity, cortico-dependent asthma, and pheochromocytoma. Oral Surg Oral Med Oral Pathol 1992;74:687-91
   PubMedGoogle Scholar
• Tofoli GR, Cereda CM, Groppo FC, Efficacy of liposome-encapsulated mepivacaine for infiltrative anesthesia in volunteers. J Liposome Res 2011;21:88-94
   PubMed Web of Science ®Google Scholar
• Franz-Montan M, de Paula E, Groppo FC, Efficacy of liposome-encapsulated 0.5% ropivacaine in maxillary dental anaesthesia. Br J Oral Maxillofac Surg 2012;50:454-8
   PubMed Web of Science ®Google Scholar
• Cereda CM, Tófoli GR, de Brito Junior RB, Stability and local toxicity evaluation of a liposomal prilocaine formulation. J Liposome Res 2008;18:329-39
   PubMed Web of Science ®Google Scholar
• Cohen R, Kanaan H, Grant GJ, Barenholz Y. Prolonged analgesia from bupisome and bupigel formulations: from design and fabrication to improved stability. J Control Release 2012;160:346-52
   PubMed Web of Science ®Google Scholar